About 4 Trademarks found that are owned by Curevac Rna PrInter Gmbh

(Based on 44(e)) Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovacular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; Pharmaceutical and veterinary preparations; Pharmaceuticals and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for treatment of infectious diseases, allergies, autoimmune disorder and tumour diseases, for treatment of metabolic disorders and for treatment of inherited genetic disease or for protein or enzyme replacement therapy; Gene therapeutic preparations, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Health care products, namely, bacterioligical, or bacterial, or vitamin, or sanitary preparations for medical use; Dietetic substances adapted for medical use, in particular substances for food supplements

(Based on 44(e)) Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes

Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements

Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes

Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements namely, dietary food supplements

Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes

Laboratory apparatus and instruments, namely, pre-packed columns for use in chemical synthesis; mobile laboratory robots with artificial intelligence for use in scientific, diagnostic and pharmaceutical research and for use in pharmaceutical production and laboratory automation; mobile device for the synthesis of macromolecules, namely, for therapeutic and preventive treatment of tumor diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; Mobile production station of biological macromolecules, namely, for therapeutic and preventive treatment of tumor diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; bioreactors for growing cells

Machines for use in chemical or biopharmaceutical industry, namely for the synthesis of macromolecules; Bioreactors for the synthesis of macromolecules; Filling machines, in particular for use for filling biopharmaceutical compositions into containers; Industrial robots